Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleTeaching Case Studies

Combined 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option

Aadil Adnan and Sandip Basu
Journal of Nuclear Medicine Technology September 2020, 48 (3) 292-294; DOI: https://doi.org/10.2967/jnmt.119.237354
Aadil Adnan
Radiation Medicine Centre, Bhabha Atomic Research Centre, and Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandip Basu
Radiation Medicine Centre, Bhabha Atomic Research Centre, and Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 48 no. 3 292-294
DOI 
https://doi.org/10.2967/jnmt.119.237354
PubMed 
32358042

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication September 25, 2019
  • Accepted for publication March 16, 2020
  • Published online September 3, 2020.

Article Versions

  • previous version (May 1, 2020 - 08:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Aadil Adnan and
  2. Sandip Basu
  1. Radiation Medicine Centre, Bhabha Atomic Research Centre, and Homi Bhabha National Institute, Mumbai, India
  1. For correspondence or reprints contact: Sandip Basu, Radiation Medicine Centre (BARC), Tata Memorial Hospital Annexe, Bhabha Atomic Research Centre, Mumbai, 400012, India. E-mail: drsanb{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The value of 68Gallium‐DOTATATE PET/CT in sinonasal neuroendocrine tumor management: A case series
    Katherine Y. Liu, David Y. Goldrich, Sen J. Ninan, Andrey Filimonov, Hansen Lam, Satish Govindaraj, Alfred Marc Iloreta
    Head & Neck 2021 43 6
  • Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model
    Marina Simón, Jesper Tranekjær Jørgensen, Harshvardhan A. Khare, Camilla Christensen, Carsten Haagen Nielsen, Andreas Kjaer
    Pharmaceutics 2022 14 6
  • p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
    Hanna Berglund, Sara Lundsten Salomonsson, Tabassom Mohajershojai, Fernando Jose Ferrer Gago, David P. Lane, Marika Nestor
    European Journal of Nuclear Medicine and Molecular Imaging 2024 51 3
  • Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal Malignancies
    Elisabetta Xue, Dara Bracken-Clarke, Harris Krause, Tolulope Adeyelu, Mark G. Evans, Dilara Akbulut, Martha Quezado, Nishant Gandhi, Alex Farrell, Heloisa P. Soares, Emil Lou, Minh Phan, Rusha Patel, Ari M. Vanderwalde, Andrew Elliott, Conor E. Steuer, Nabil F. Saba, Daniel J. Lubin, Nyall R. London, James L. Gulley, Charalampos S. Floudas
    Cancers 2024 16 23
  • Critical Issues in Head and Neck Oncology
    Marco Ferrari, Stefano Taboni, Giacomo Contro, Piero Nicolai
    2023
  • Metachronous Second Primary in the Form of Nasopharyngeal Carcinoma Following Treatment of Small Cell Neuroendocrine Carcinoma of the Head and Neck: Dual Tracer PET/CT Findings Highlighting SSTR2 Expression and Its Theranostic Implications
    Yeshwanth Edamadaka, Sunita Nitin Sonavane, Sandip Basu
    World Journal of Nuclear Medicine 2024 23 04
  • Panelsequenzierung in der Kopf-Hals-Onkologie am Beispiel von sinunasalen und Speicheldrüsenmalignomen
    Abbas Agaimy, Sarina K. Müller
    Die Onkologie 2023 29 1

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 202025806
Jun 202011803
Jul 20205700
Aug 20206004
Sep 202016428
Oct 202014721
Nov 202013001
Dec 20207012
Jan 20217522
Feb 20213720
Mar 20214500
Apr 202111011
May 20214710
Jun 20216165
Jul 20214526
Aug 20212403
Sep 202118126
Oct 2021242212
Nov 20218246
Dec 2021242711
Jan 202210169
Feb 202211175
Mar 2022121513
Apr 20228125
May 2022101822
Jun 20222811
Jul 2022565
Aug 2022111212
Sep 202213910
Oct 202261715
Nov 20221094
Dec 20224114
Jan 20236107
Feb 20234126
Mar 202311118
Apr 20235204
May 2023122810
Jun 20239169
Jul 20231289
Aug 202318117
Sep 20231395
Oct 202381212
Nov 202391611
Dec 20237248
Jan 20246109
Feb 20248215
Mar 20245841
Apr 202482415
May 20244579
Jun 2024131614
Jul 202461318
Aug 202422222
Sep 2024322126
Oct 202441420
Nov 202415179
Dec 20246217
Jan 20254237
Feb 20259409
Mar 2025155122
Apr 2025112932
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 48 (3)
Journal of Nuclear Medicine Technology
Vol. 48, Issue 3
September 1, 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Combined 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Combined 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
Aadil Adnan, Sandip Basu
Journal of Nuclear Medicine Technology Sep 2020, 48 (3) 292-294; DOI: 10.2967/jnmt.119.237354

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Combined 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
Aadil Adnan, Sandip Basu
Journal of Nuclear Medicine Technology Sep 2020, 48 (3) 292-294; DOI: 10.2967/jnmt.119.237354
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-Sensitivity Troponin Elevation in a Young Woman with Typical Chest Pain: The Heart of the Matter
  • Pulmonary Adenocarcinoma Revealed by Parathyroid Scintigraphy: An Incidental Case to Remember
  • Prominent Right Ventricular Tracer Uptake: A Harbinger of Multivessel Coronary Artery Disease
Show more Teaching Case Studies

Similar Articles

Keywords

  • Sinonasal Neuroendocrine carcinoma
  • 68Ga-DOTATATE PET/CT
  • 18F-FDG PET/CT
  • 177Lu-DOTATATE
  • Peptide Receptor Radionuclide Therapy
  • dual-tracer PET/CT
SNMMI

© 2025 SNMMI

Powered by HighWire